These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 984798)

  • 1. Antiviral effects of virazole in chronic hepatitis B surface antigen-seropositive chimpanzees.
    Denes AE; Ebert JW; Berquist KR; Murphy BL; Maynard JE
    Antimicrob Agents Chemother; 1976 Sep; 10(3):571-2. PubMed ID: 984798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B outbreak among chimpanzees at the London Zoo.
    Zuckerman AJ; Thornton A; Howard CR; Tsiquaye KN; Jones DM; Brambell MR
    Lancet; 1978 Sep; 2(8091):652-4. PubMed ID: 80578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Action of an anti-viral on the Australia antigen in patients with hepatitis A virus and in healthy carriers].
    Vilela MD; Siqueira WA; Rodriguez LD; Domingues SH; Rodrigues FD
    G E N; 1977; 31(3):149-55. PubMed ID: 97122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B e-antigen and its correlation with other serological markers in chimpanzees.
    Ling CM; Mushahwar IK; Overby LR; Berquist KR; Maynard JE
    Infect Immun; 1979 May; 24(2):352-6. PubMed ID: 457278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay of HBV DNA in the plasma of HBV-carrier chimpanzees superinfected with non-A, non-B hepatitis.
    Harrison TJ; Tsiquaye KN; Zuckerman AJ
    J Virol Methods; 1983 May; 6(5):295-302. PubMed ID: 6409916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg.
    Wooddell CI; Yuen MF; Chan HL; Gish RG; Locarnini SA; Chavez D; Ferrari C; Given BD; Hamilton J; Kanner SB; Lai CL; Lau JYN; Schluep T; Xu Z; Lanford RE; Lewis DL
    Sci Transl Med; 2017 Sep; 9(409):. PubMed ID: 28954926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of chronic hepatitis B with a 6-month course of ribavirin.
    Fried MW; Fong TL; Swain MG; Park Y; Beames MP; Banks SM; Hoofnagle JH; Di Bisceglie AM
    J Hepatol; 1994 Aug; 21(2):145-50. PubMed ID: 7989704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant.
    Ogata N; Zanetti AR; Yu M; Miller RH; Purcell RH
    J Infect Dis; 1997 Mar; 175(3):511-23. PubMed ID: 9041321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of seropositive occult hepatitis B viral infection in lymphoma patients receiving chemotherapy.
    Cheung WI; Lin SY; Leung VK; Fung KS; Lam YK; Lo FH; Chau TN
    Hong Kong Med J; 2011 Oct; 17(5):376-80. PubMed ID: 21979474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infectivity of hepatitis B].
    Gerken G
    Dtsch Med Wochenschr; 1996 Apr; 121(14):459. PubMed ID: 8665822
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of specific effect of adenine arabinoside, human interferon, and ribavirin on in vitro production of hepatitis B surface antigen.
    Lemon SM; Bancroft WH
    J Infect Dis; 1979 Nov; 140(5):798-801. PubMed ID: 528792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the inhibiting action of virazole on the reproduction of the vaccinia virus in tissue culture].
    Chizhov NP
    Vopr Virusol; 1979; (3):259-62. PubMed ID: 380162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
    Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of virazole on the antiviral activity of poly(G) X poly(C) and other polyribonucleotide interferonogens].
    Vil'ner LM; Lashkevich VA
    Antibiotiki; 1984 Jun; 29(6):450-3. PubMed ID: 6089650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic tubular structures in liver of HBsAg carrier chimpanzees infected with delta agent and comparison with cytoplasmic structures in non-A, non-B hepatitis.
    Kamimura T; Ponzetto A; Bonino F; Feinstone SM; Gerin JL; Purcell RH
    Hepatology; 1983; 3(5):631-7. PubMed ID: 6413349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees.
    Rizzetto M; Hoyer B; Canese MG; Shih JW; Purcell RH; Gerin JL
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6124-8. PubMed ID: 6934539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hepatitis A infection in hepatitis B chimpanzee carriers.
    Tsiquaye KN; Harrison TJ; Portmann B; Hu S; Zuckerman AJ
    Hepatology; 1984; 4(3):504-9. PubMed ID: 6724518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of influenza RNA synthesis by virazole (ribavirin).
    Scholtissek C
    Arch Virol; 1976; 50(4):349-52. PubMed ID: 1275709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of virazole (ribavirin) on the replication of tomato white necrosis virus (VNBT).
    de Fazio G; Caner J; Vicente M
    Arch Virol; 1978; 58(2):153-6. PubMed ID: 708266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vaccinia virus growth by the nucleoside analogue 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ribavirin).
    Katz E; Margalith E; Winer B
    J Gen Virol; 1976 Aug; 32(2):327-30. PubMed ID: 1018177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.